Text Size

Countering Stimulus-Induced Alpha-Desynchronization to Treat Tinnitus

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Nathan Weisz, University of Konstanz
ClinicalTrials.gov Identifier:
NCT00748475
First received: September 5, 2008
Last updated: February 19, 2013
Last verified: February 2013
History of Changes
  Purpose

The purpose of the study is to examine the effect of alpha-neurofeedback while subjects listen to a noise on tinnitus.


Condition Intervention
Tinnitus
 Behavioral: Neurofeedback

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Countering Stimulus-Induced Alpha-Desynchronization to Treat Tinnitus

Resource links provided by NLM:

MedlinePlus related topics: Tinnitus
U.S. FDA Resources

Further study details as provided by University of Konstanz:

Primary Outcome Measures:
  • Reduction of tinnitus distress using the Tinnitus Questionaire [ Time Frame: Before the first and after the last session. ] [ Designated as safety issue: No ]
  • Cortical Alpha Power [ Time Frame: Before the first and after the last session ] [ Designated as safety issue: No ]

Enrollment: 12
Study Start Date: September 2008
Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Neurofeedback Behavioral: Neurofeedback

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Duration of Tinnitus >= 6 months and <= 20 years
  • Subjective Tinnitus

Exclusion Criteria:

  • History of neurological or more than mild psychiatric diseases
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00748475

Sponsors and Collaborators
University of Konstanz
Investigators
Principal Investigator: Nathan Weisz, PhD University Konstanz
Study Chair: Thomas Hartmann, Dipl.-Psych. University Konstanz
  More Information

No publications provided

Responsible Party: Nathan Weisz, Dr. Nathan Weisz, University of Konstanz
ClinicalTrials.gov Identifier: NCT00748475     History of Changes
Other Study ID Numbers: TE0602-1
Study First Received: September 5, 2008
Last Updated: February 19, 2013
Health Authority: Germany: Ethics Commission

Additional relevant MeSH terms:
Tinnitus
Hearing Disorders
Ear Diseases
Otorhinolaryngologic Diseases
 Sensation Disorders
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on May 22, 2013